Zacks Investment Research on MSN
Riding the marijuana reclassification wave: 3 stocks to watch in 2026
After years of muted growth and battered stock prices, the sector finally began showing signs of life as long-awaited regulatory progress moved closer to reality. Earlier this month, President Trump ...
Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ( ...
As the trading year 2025 draws to a close, the cannabis sector presents a confusing picture for the average investor. On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the ...
Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December 2025 ...
Tilray Stock surged 35x on U.S. cannabis reform hopes. Learn what’s driving gains, risks ahead and what investors should watch next.
Cannabis company Tilray Brands has become the center of Wall Street attention as shares rocketed 17.52% following reports that President Trump is considering reclassifying marijuana from its current ...
Analysts covering the sector have turned more constructive on cannabis stocks, citing improved regulatory clarity and ...
Tilray Brands is riding a perfect storm of cannabis industry catalysts that sent the stock climbing on Monday, Dec. 15, 2025. The company finds itself at the intersection of Washington policy ...
TLRY stock has risen following a CNBC report citing optimism over potential federal rules for hemp-derived products and indications that President Donald Trump may relax marijuana restrictions. Shares ...
Shares of Village Farms International VFF have skyrocketed 328% year to date, significantly outperforming the industry’s 10% decline. This upside can be largely attributed to favorable comments from ...
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana ...
President Trump signed an executive order, which directed federal agencies to finish the process of rescheduling cannabis to a Schedule III substance. The cannabis sector had experienced a rally over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results